SAM#8451
A - Research and Development
SAMDaily.us: AWARDS - January 16, 2025
- 75N93024C00019 - 2000000.00
NANOVACCINE FOR ELICITING BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV-1
NEOVAXSYN INC Ames IA 50014 USA
- 75N93024C00018 - 1999866.00
DESIGN AND ENGINEERING OF VESIVAXÏ¿½ HIV IMMUNOGEN FORMULATIONSÏ¿½
MOLECULAR EXPRESS, INC Rancho Dominguez CA 90220 USA
| This Issue's Index | Today's SAM Daily Index Page |
Created on 14-Jan-2025 by Loren Data Corp. -- info@samdaily.us